Sign In
Buy NNOX
$1.51
-0.110 (-6.79%)
At Close: Jun 23, 2026
Why Is Everybody Talking About Nano-X Stock?
06:37am, Thursday, 29'th Oct 2020
The company's new X-ray will be a lot cheaper than existing technology. If it works as advertised, the device might be a game changer.
NEW YORK, Oct. 28, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX), between August 21, 2020 and Septe
New York, New York--(Newsfile Corp. - October 28, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
New York, New York--(Newsfile Corp. - October 27, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Nano-X Imaging Ltd. (NASDAQ: NNOX) alle
New York, New York--(Newsfile Corp. - October 27, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
3 Green Flags for Nano-X's Future
06:57am, Sunday, 25'th Oct 2020
The only thing left to prove is that its X-ray technology actually works.
U.S. IPO Week Ahead: The IPO Market Braces For A September SNOWstorm In A 12-IPO Week
11:07am, Sunday, 13'th Sep 2020
The post-Labor Day IPO frenzy is here as 12 IPOs plan to raise $6.8 billion in the coming week, led by cloud data unicorn Snowflake.
U.S. IPO Weekly Recap: Biotechs And SPACs Ride The Summer Wave In A 4 IPO Week
06:48am, Sunday, 23'rd Aug 2020
Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. The week's eight SPAC IPOs raised $3.3 billion.
IPO Update: Nano-X Imaging Seeks $100 Million U.S. IPO
12:04pm, Monday, 17'th Aug 2020
Nano-X Imaging has filed proposed terms for its U.S. IPO.
U.S. IPO Week Ahead: The IPO Market's Summer Slowdown Approaches In A 3-IPO Week
03:41pm, Saturday, 15'th Aug 2020
Two biotechs, a medical imaging company, and two SPACs are scheduled to go public in the week ahead. Another biotech, Kymera Therapeutics, is eligible to launch.
